| 000 | 03592nam a2200433 c 4500 | ||
|---|---|---|---|
| 710 | 2 |
_aSpringerLink (Online service) _9106996 |
|
| 999 |
_c117893 _d117893 _x1 |
||
| 001 | 117893 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102113832.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 191106s2019 si a o |||| 0|eng d | ||
| 020 | _a9789811394355 | ||
| 024 | 7 |
_a10.1007/978-981-13-9435-5 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQK603 _b2019 EB |
|
| 245 | 0 | 0 |
_aRecent Trends in Human and Animal Mycology _cedited by Karuna Singh, Neelabh Srivastava. |
| 250 | _aFirst edition | ||
| 264 | 1 |
_aSingapore _bSpringer International Publishing _c2019 |
|
| 300 |
_a1 recurso en línea (XVII, 280 páginas) _b81 ilustraciones, 51 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 | _aBiomedical and Life Sciences (Springer-11642) | |
| 505 | 0 | _aPart I Human and Animal Mycoses -- Pythiosis -- Superficial Mycoses in Dogs and Cats -- Pathogenic Chrysosporium-related Fungi in Reptiles and Other Animals -- Aspergillosis in Humans and Animals -- Some Clinically Significant Genera of Dematiaceous Hyphomycetes: An Update -- Endemic Mycoses in Americas -- Part II Mycotoxins in Relation to Human and Animal Health -- Mycotoxins and Their Inhalatory Intake Risk -- Tenuazonic acid:A Potent Mycotoxin -- Part III Antifungal Therapeutic Candidates -- Phytochemicals: New Avenues in Anti-Candidal Activity -- Recent Advances in Coumarins as Antifungal Agents. | |
| 520 | 3 | _aFungal pathogens pose an on-going and serious threat for poikilotherms and homeotherms, and can cause a broad spectrum of diseases ranging from innocuous to life-threatening. In addition, long-term exposure to some mycotoxigenic moulds can lead to mycotoxicoses in human and animals. Given the expanding population of immune compromised hosts, the list of fungal opportunists grows longer every year. Moreover, antifungal resistance, drug-related toxicity and our limited arsenal of antifungals have exacerbated the situation. To address these problems, strategies such as the identification of novel targets, use of the structure-activity relationship in rational drug design, development of new formulations, modification of existing antifungals to combat resistance, and bioavailability enhancement are called for. For the reader's convenience, this book has been divided into three sections. The first six chapters of Section I provide a timely review of mycoses, from endemic to cosmopolitan and from generalized to specific, while both chapters of Section II focus on risks associated with mycotoxins. In closing, the two chapters of Section III describe potential antifungal leads and drug candidates based on phytochemicals and coumarin scaffold. | |
| 988 | _aPrimersemestre_2020_BiomedLife | ||
| 650 | 7 |
_2embne _9138682 _aMicología |
|
| 700 | 1 |
_aSingh, Karuna _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aSrivastava, Neelabh _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811394348 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811394362 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811394379 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-9435-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE _n0 |
||
| 998 |
_b03/2020 _dz _ek _zSI |
||